Statement of Need

This conference will review the benefits of developing an effective treatment strategy for patients who have not responded adequately to other treatments. The focus will be on the impact of various treatment options on patients' quality of life.  Finally, clinical trials and future directions of treatment will be discussed.

 

Target Audience

This conference is designed to address the continuing medical education needs of neurologists and other healthcare professionals who manage patients with multiple sclerosis.

 

Learning Objectives

After attending this event, you should be able to:

1. Develop an approach to assessing the place of new therapies in the treatment of multiple sclerosis.
2. Recognize alternative strategies for selecting a starting drug and switching.
3. Highlight new, and potential future, treatments for multiple sclerosis.

​​

Accreditation

Physician Continuing Medical Education Credit

This is a demo program, University Clinic is NOT accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

University Clinic designates this demo educational activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 

Continuing Pharmacy Education Credit

This demo activity has been planned and implemented by the University Clinic Health System Department of Clinical Education and Professional Development and The University Clinic Cancer Network. University Clinic is NOT accredited by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing education for the healthcare team.

University Clinic designates this knowledge-based activity for a maximum of 3.5 ACPE contact hours.
Universal Activity Number: 0851-9999-16-250-H01-P
 

Where

Lakeside Medical Center
897 Wrightsville Blvd
Norfolk, VA 26586

 

Agenda

9am - Opening Remarks (30 min.)

Keynote Speaker: Assessing the place of new therapies in the treatment of multiple sclerosis (2.5 hrs)

11pm - Closing Remarks (30 min.)

Keynote Speaker:
 

John H. McKenley

PhD, Administrator, National Admin Administration (NAA)
Disclosures: There is nothing for this person to disclose. 

Policy on Faculty and Sponsor Disclosure

It is the policy of the Rievent Technologies that the faculty, authors, planners, and other persons who may influence the content of this CME activity disclose all relevant financial relationships with commercial interests in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.